<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03883711</url>
  </required_header>
  <id_info>
    <org_study_id>600/2018/Oss/AOUBo</org_study_id>
    <nct_id>NCT03883711</nct_id>
  </id_info>
  <brief_title>Acute Myocardial Infarction: Prognosis and Therapy</brief_title>
  <acronym>IMAPA</acronym>
  <official_title>Acute Myocardial Infarction From Clinical Presentation to Strategy Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      IMAPA is both a retrospective and prospective study which was designed in order to collect
      data of patients with acute coronary syndromes and myocardial injury and to improve the
      knowledge about these conditions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      IMAPA is an observational, multicenter and both retrospective and prospective study enrolling
      a cohort of consecutive incident patients admitted to participating hospitals with a
      diagnosis of acute coronary syndrome or myocardial injury from 01/01/2016 to 31/12/2023.

      The aim of this study is to create a database including a comprehensive characterization of
      these patients in order to obtain new scientific evidence about these conditions.
      Informations about the patients will be gathered from in-hospital medical records. A written
      informed consent is needed for every prospective patients enrolled in the study,

      In particular, the main objectives of the study are:

        -  document the characteristics of all patients presenting with acute coronary syndrome and
           myocardial injury;

        -  document the long term outcome rates;

        -  document the therapeutic regimens and investigation conformity of treatment with already
           established guidelines.

      Every diagnostic or therapeutic intervention will be in accordance with established
      guidelines and good clinical practice.

      Statistics will be conducted utilizing univariate and multivariate analysis for outcomes. In
      particular for what concerns univariate analysis, ordinal variables will be analysed with
      t-test and Mann-Whitney Test, whereas categorical responses with Fischer Exact Test and with
      Pearson Chi-square test.

      Multivariate analysis will be conducted with logistic regression for dichotomous variables,
      with mixed generalized linear model for ordinal or nominal variables and with ANOVA or MANOVA
      for continuous variables.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Death rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>3 years</time_frame>
    <description>Death rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>5 years</time_frame>
    <description>Death rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiac Events (MACEs)</measure>
    <time_frame>1 year</time_frame>
    <description>MACEs rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiac Events (MACEs)</measure>
    <time_frame>3 years</time_frame>
    <description>MACEs rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiac Events (MACEs)</measure>
    <time_frame>5 years</time_frame>
    <description>MACEs rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular risk factors prevalence</measure>
    <time_frame>1 year</time_frame>
    <description>Differences in percentage of patients with STEMI or NSTEMI, or type 1 or type 2 myocardial infarction with any risk factors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular risk factors prevalence</measure>
    <time_frame>3 year</time_frame>
    <description>Differences in percentage of patients with STEMI or NSTEMI, or type 1 or type 2 myocardial infarction with any risk factors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular risk factors prevalence</measure>
    <time_frame>5 year</time_frame>
    <description>Differences in percentage of patients with STEMI or NSTEMI, or type 1 or type 2 myocardial infarction with any risk factors</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in clinical presentation</measure>
    <time_frame>3 year</time_frame>
    <description>Prevalence of patients presenting with ST elevation, angina, dyspnea, atypical chest pain, cardiogenic shock, arrhytmias)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in clinical presentation</measure>
    <time_frame>1 year</time_frame>
    <description>Prevalence of patients presenting with ST elevation, angina, dyspnea, atypical chest pain, cardiogenic shock, arrhytmias)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in clinical presentation</measure>
    <time_frame>5 year</time_frame>
    <description>Prevalence of patients presenting with ST elevation, angina, dyspnea, atypical chest pain, cardiogenic shock, arrhytmias)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference diagnosis between myocardial infarction subtypes and between myocardial infarction and myocardial injury</measure>
    <time_frame>5 year</time_frame>
    <description>Differences in clinical presentation (ST elevation, angina, dyspnea, atypical chest pain, cardiogenic shock, arrhytmias)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in flow characteristics</measure>
    <time_frame>1 year</time_frame>
    <description>TIMI, TIMI frame count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in flow characteristics</measure>
    <time_frame>3 year</time_frame>
    <description>TIMI, TIMI frame count</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Differences in flow characteristics</measure>
    <time_frame>5 year</time_frame>
    <description>TIMI, TIMI frame count</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">11000</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Myocardium; Injury</condition>
  <arm_group>
    <arm_group_label>Patients with acute coronary syndrome or myocardial injury</arm_group_label>
    <description>Incident consecutive patients presenting with acute coronary syndrome or myocardial injury</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Database</intervention_name>
    <description>Create a database containing clinical characteristic, clinical presentation, flow indexes and treatment of consecutive incident patients with ACS or myocardial injury.</description>
    <arm_group_label>Patients with acute coronary syndrome or myocardial injury</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients admitted with a diagnosis of acute coronary syndrome or myocardial injury
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient aged &gt; 18 years old

          -  Acute coronary syndrome or myocardial injury

          -  Written informed consent

        Exclusion Criteria:

          -  under age or not able to give informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carmine Pizzi, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Bologna, Cardiology Department</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carmine Pizzi, Dr</last_name>
    <phone>0039 (0)512144933</phone>
    <email>carmine.pizzi@unibo.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Policlinico Sant'Orsola-Malpighi, Cardiology Department</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carmine Pizzi, Dr</last_name>
      <phone>0039 (0)512144933</phone>
      <email>carmine.pizzi@unibo.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Bonaca MP, Wiviott SD, Braunwald E, Murphy SA, Ruff CT, Antman EM, Morrow DA. American College of Cardiology/American Heart Association/European Society of Cardiology/World Heart Federation universal definition of myocardial infarction classification system and the risk of cardiovascular death: observations from the TRITON-TIMI 38 trial (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis in Myocardial Infarction 38). Circulation. 2012 Jan 31;125(4):577-83. doi: 10.1161/CIRCULATIONAHA.111.041160. Epub 2011 Dec 23.</citation>
    <PMID>22199016</PMID>
  </reference>
  <reference>
    <citation>Sandoval Y, Smith SW, Sexter A, Thordsen SE, Bruen CA, Carlson MD, Dodd KW, Driver BE, Hu Y, Jacoby K, Johnson BK, Love SA, Moore JC, Schulz K, Scott NL, Apple FS. Type 1 and 2 Myocardial Infarction and Myocardial Injury: Clinical Transition to High-Sensitivity Cardiac Troponin I. Am J Med. 2017 Dec;130(12):1431-1439.e4. doi: 10.1016/j.amjmed.2017.05.049. Epub 2017 Jul 21.</citation>
    <PMID>28739197</PMID>
  </reference>
  <reference>
    <citation>Baron T, Hambraeus K, Sundström J, Erlinge D, Jernberg T, Lindahl B; TOTAL-AMI study group. Type 2 myocardial infarction in clinical practice. Heart. 2015 Jan;101(2):101-6. doi: 10.1136/heartjnl-2014-306093. Epub 2014 Oct 20.</citation>
    <PMID>25331532</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 15, 2019</study_first_submitted>
  <study_first_submitted_qc>March 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 21, 2019</study_first_posted>
  <last_update_submitted>March 18, 2019</last_update_submitted>
  <last_update_submitted_qc>March 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi</investigator_affiliation>
    <investigator_full_name>Carmine Pizzi</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Acute coronary syndrome</keyword>
  <keyword>Myocardial injury</keyword>
  <keyword>ACS</keyword>
  <keyword>MINOCA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

